Icon

GEODON (nda020825)- (EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE)

ZIPRASIDONE HYDROCHLORIDE VIATRIS
EQ 20MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE
Yes No
2019-May-27 Expired
None None
None No
GEODON is indicated as an oral formulation for the: Treatment of schizophrenia, Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder, Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate,
8 0 8
Total Other Developers None
Drugs with Suitability No
EQ 20MG BASE ** ** - 6 1
EQ 40MG BASE ** ** - - 7
EQ 60MG BASE ** ** - 6 1
EQ 80MG BASE ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ***** ****** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ***** ****** ***** ******* *********** ****-*, **** **. ***, ***, ****** - **, ******* ******** ****, *****, ******, *********** ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** **-**, ****** ** *** ******* ********** ****** ********, *****, ***** ******, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ****** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.